Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Conway

Showing results (81-90 of 87) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 87 results.
Journal of Medicinal Chemistry|November 1, 1988
Structure-activity relationships among analogues of pemedolac, cis-1-ethyl-1,3,4,9-tetrahydro-4-(phenylmethyl)pyrano[3,4-b]indo le-1-a cetic acid, a potent analgesic agentD Mobilio, L G Humber, A H Katz, et al.
Science (New York, N.Y.)|February 15, 1991
Senescence of nickel-transformed cells by an X chromosome: possible epigenetic controlC B Klein, K Conway, X W Wang, et al.
Neurology|June 1, 1994
The effects of 4-aminopyridine in multiple sclerosis patients: results of a randomized, placebo-controlled, double-blind, concentration-controlled, crossover trialC T Bever, D Young, P A Anderson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2000
HER-2/neu amplification in benign breast disease and the risk of subsequent breast cancerA Stark, B S Hulka, S Joens, et al.
Carcinogenesis|February 1, 1987
Physicochemical characteristics and biological effects of nickel oxidesF W Sunderman, S M Hopfer, J A Knight, et al.
Journal of Interferon Research|October 1, 1993
Systemic recombinant human interferon-beta treatment of relapsing-remitting multiple sclerosis: pilot study analysis and six-year follow-upR L Knobler, J I Greenstein, K P Johnson, et al.
HIV Medicine|July 23, 2015
Lopinavir and atazanavir in pregnancy: comparable infant outcomes, virological efficacies and preterm delivery ratesM E O Perry, G P Taylor, C A Sabin, et al.
Pageof 9

Showing results (81-90 of 87) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 87 results.
Journal of Medicinal Chemistry|November 1, 1988
Structure-activity relationships among analogues of pemedolac, cis-1-ethyl-1,3,4,9-tetrahydro-4-(phenylmethyl)pyrano[3,4-b]indo le-1-a cetic acid, a potent analgesic agentD Mobilio, L G Humber, A H Katz, et al.
Science (New York, N.Y.)|February 15, 1991
Senescence of nickel-transformed cells by an X chromosome: possible epigenetic controlC B Klein, K Conway, X W Wang, et al.
Neurology|June 1, 1994
The effects of 4-aminopyridine in multiple sclerosis patients: results of a randomized, placebo-controlled, double-blind, concentration-controlled, crossover trialC T Bever, D Young, P A Anderson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2000
HER-2/neu amplification in benign breast disease and the risk of subsequent breast cancerA Stark, B S Hulka, S Joens, et al.
Carcinogenesis|February 1, 1987
Physicochemical characteristics and biological effects of nickel oxidesF W Sunderman, S M Hopfer, J A Knight, et al.
Journal of Interferon Research|October 1, 1993
Systemic recombinant human interferon-beta treatment of relapsing-remitting multiple sclerosis: pilot study analysis and six-year follow-upR L Knobler, J I Greenstein, K P Johnson, et al.
HIV Medicine|July 23, 2015
Lopinavir and atazanavir in pregnancy: comparable infant outcomes, virological efficacies and preterm delivery ratesM E O Perry, G P Taylor, C A Sabin, et al.
Pageof 9